Method of detection by inducing electrochemiluminescence

Abstract: This invention is related to electrochemiluminescent labels useful in the detection of an analyte. One of these labels is a compound having the formula (A) k (B) u wherein A is a compound which can be induced to repeatedly emit electromagnetic radiation by direct exposure to an electrochemical energy source; B is a substance which is attached to A; and k and u are integers equal or greater than 1. A can be inorganic, organometallic or can be an organic compound, e.g. rubrene or 9,10-diphenyl anthracene. B can be a biological or nonbiological substance. The attachment between A and B may be by coordination to a metal atom present in A or to a ligand of A. Another label has the formula [M(P) m( L¹) n( L²) o( L³) p( L⁴) q( L⁵) r( L⁶) s ] t (B) u wherein M is ruthenium or osmium, P is a polydentate ligand of M, and the L's are ligands of M. At least one polydentate ligand must be present. B is a substance covalently bound to one or more of the ligands P and L through one ore more amide or amine linkages.

Description: Background of the Invention There is a continuous and expanding need for rapid, highly specific methods of detecting and quantifying chemical, biochemical, and biological substances. Of particular value are methods for measuring small quantities of pharmaceuticals, metabolites, microorganisms and other materials of diagnostic value. Examples of such materials include narcotics and poisons, drugs administered for therapeutic purposes, hormones, pathogenic microorganisms and viruses, antibodies, metabolites, enzymes and nucleic acids. The presence of these materials can often be determined by binding methods which exploit the high decree of specificity which characterizes many biochemical and biological systems. Frequently used methods are based on, for example, antigen-antibody systems, nucleic acid hybridization techniques, and protein-ligand systems. In these methods, the existence of the complex of diagnostic value Is typically indicated by the presence or absence of an observable "label" which has been attached to one or more of the complexing materials. The specific labelling method chosen often dictates the usefulness and versatility of a particular system for detecting a material of interest. A preferred label should be inexpensive, safe, and capable of being attached efficiently to a wide variety of chemical, biochemical, and biological materials without changing the important binding characteristics of those materials. The label should give a highly characteristic signal, and should be rarely, or preferably never found in nature. The label should be stable and detectable in aqueous systems over periods of time ranging up to months. Detection of the label should be rapid, sensitive, and reproducible without the need for expensive, specialized facilities or personnel. Quantification of the label should be relatively independent of variables such as temperature and the composition of the mixture to be assayed. Most advantageous are labels which can be used in homogeneous systems, i.e. systems in which separation of the complexed and uncomplexed labelled material is not necessary. This is possible if the detectability of the label is modulated when the labelled material is incorporated into a specific complex. A wide variety of labels have been developed, each with particular advantages and disadvantages. For example, radioactive labels are quite versatile, and can be detected at very low concentrations. However, they are expensive, hazardous, and their use requires sophisticated equipment and trained personnel. Furthermore, the sensitivity of radioactive labels is limited by the fact that the detectable event can, In its essential nature, occur only once per radioactive atom in the labelled material. Moreover, radioactive labels cannot be used In homogeneous methods. Thus, there is wide interest in non-radioactive labels. These include molecules observable by spectrophotometric, spin resonance, and luminescence techniques, as well as enzymes which produce such molecules. Among the useful non-radioactive labelling materials are organometallic compounds. Because of the rarity of some metals in biological systems, methods which specifically assay the metal component of the organometallic compounds can be successfully exploited. For example, Cais, U.S. Patent No. 4,205,952 discloses the use of immunochemically active materials labelled with certain organometallic compounds for use in quantitating specific antigens. Any general method of detecting the chosen metals can be used with these labels, including emission, absorption and fluorescence spectrometry. atomic absorption, and neutron activation. These methods often suffer from lack of sensitivity, can seldom be adapted to a homogenous system, and as with atomic absorption, sometimes entail destruction of the sample. Of particular interest are labels which can be made to luminesce through photochemical, chemical, and electrochemical means. "Photoluminescence" is the process whereby a material is induced to luminesce when it absorbs electromagnetic radiation. Fluorescence and phosphorescence are types of photoluminescence. "Chemiluminescent" processes entail the creation of the luminescent species by a chemical transfer of energy. "Electrochemiluminescence" entails the creation of the luminescent species electrochemically. These luminescent systems are of increasing importance. For example, Mandle, U.S. Patent No. 4,372,745 discloses the use of chemiluminescent labels in immunochemical applications. In the disclosed systems, the labels are excited into a luminescent state by chemical means such as by reaction of the label with H 2 O 2 and an oxalate. In these systems, H 2 O 2 oxidatively converts the oxalate into a high energy derivative, which then excites the label. This system will, in principle, work with any luminescent material that is stable in the oxidizing conditions of the assay and can be excited by the high energy oxalate derivative. Unfortunately, this very versatility is the source of a major limitation of the technique: typical biological fluids containing the analyte of interest also contain a large number of potentially luminescent substances that can cause high background levels of luminescence. Another example of the immunochemical use of chemiluminescence which suffers from the same disadvantages is Oberhardt et al., U.S. Patent No. 4,280,815, who disclose the in situ electrochemical generation of an oxidant (e.g., H 2 O 2 ) in close proximity to an immunoreactant labelled with a chemiluminescent species. The electrogenerated oxidant diffuses to the chemiluminescent species and chemically oxidizes it, resulting in the net transfer of one or more electrons to the electrogenerated oxidant. Upon oxidation, the chemiluminescent species emits a photon. In contrast, the subject invention requires the direct transfer of electrons from a source of electrochemical energy to a chemiluminescent species which is capable of repeatedly emitting photons. The present invention is concerned with electrochemiluminescent labels. Suitable labels comprise electrochemiluminescent compounds, including organic compounds and organometallic compounds. Electrochemiluminescent methods of determining the presence of labelled materials are preferred over other methods for many reasons. They are highly diagnostic of the presence of a particular label, sensitive, nonhazardous, inexpensive, and can be used in a wide variety of applications. Organic compounds which are suitable electrochemical labels include, for example, rubrene and 9,10-diphenyl anthracene. Many organometallic compounds are suitable electrochemical labels, but of particular use are Ru-containing and Os-contalning compounds. The present invention is concerned with the use of Ru-containing and Os-containing labels which can be detected by a wide variety of methods. These labels are advantageous for many reasons that will be discussed herein. Ru-containing and Os-containing organometallic compounds have been discussed in the literature. Cais discloses that any metal element or combination of metal elements, including noble metals from group VIII such as Ru, would be suitable components of organometallic labels detectable by atomic absorption methods. (Cais, column 11, line 20). However, ruthenium is not a preferred metal in Cais, osmium is not specifically mentioned, no data is presented on the efficiency of using Ru or Os in any of the methods disclosed, and the preferred method of detection, atomic absorption, entails destruction of the sample. Weber, U.S. Patent No. 4,293,310, discloses the use of Ru-containing and Os-containing complexes as electrochemical labels for analytes in immunoassays. The disclosed complexes are linked to amino groups on the analytes through a thiourea linkage. Weber also suggests the possibility of forming carboxylate esters between the labels and hydroxy groups on other analytes. According to Weber, the presence of the labelled materials can be determined with an apparatus and method which comprises a quencher and an electrochemical flow cell with light means. The photoelectrochemically active label upon photoexcitation transfers an electron to a quencher molecule; the oxidized molecule is subsequently reduced with an electron from an electrode of the flow cell which is held at suitable potential. This electron is measured as photocurrent. The amount of free labelled analyte in the system is determined by the photocurrent signal. Note that this method is the reverse of electrochemiluminescent detection of luminescent materials. In subsequent reports, Weber et al. (1983), Clinical Chemistry 29, pp. 1665-1672, Photoelectroanalytical Chemistry: Possible Interferences in Serum and Selective Detection of Tris(2,2'-bipyridine)ruthenium(II) in the Presence of Interferents, have discussed the problems associated with the use of this method to detect Ru-containing labels. In Table 2 of Weber et al., the extrapolated detection limit for tris(bipyridyl)ruthenium(I)) Is 1.1x10 -10 moles/L, under optimal conditions. In anticipating that the actual use of these labels would entail measurements in the presence of complex mixtures, Weber et al. tested for potential interferents In their system. Table 3 of Weber et al. lists dimethylalkyl amines, EDTA, N-methylmorpholine, N,N'-dimethylpiperazine, hydroxide, oxalate, ascorbate, uric acid, and serum as interferents which would presumably raise the practical detection limit substantially above 1.1x10 -10 moles/L. These studies were performed with a simple Ru-containing compound. No studies were reported in Weber or Weber et al. regarding the limits of detection of complex substances labelled with Ru-containing labels, or on whether the thiourea linkage between the labelled material and label is stable under conditions of the assay. The particular labels with which the present invention is concerned are electrochemiluminescent. They can often be excited to a luminescent state without their oxidation or reduction by exposing the compounds to electromagnetic radiation or to a chemical energy source such as that created by typical oxalate-H 2 O 2 systems. In addition, luminescence of these compounds can be induced by electrochemical methods which do entail their oxidation and reduction. Extensive work has been reported on methods for detecting Ru(2,2-bipyridine) 3 2+ using photoluminescent, chemiluminescent, and electrochemiluminescent means: Rubinstein and Bard (1981), "Electrogenerated Chemiluminescence. 37. Aqueous Ecl Systems based on Ru(2,2'-bipyridine) 3 2+ and Oxalate or Organic Acids", J. Am. Chem. Soc., 103, pp. 512-516; and White and Bard (1982), "Electrogenerated Chemiluminescence, 41. Electrogenerated Chemiluminescence and Chemiluminescence of the Ru(2,2'-bpy) 3 2+ - S 2 O 8 2- System in Acetonitrile-Water Solutions", J. Am. Chem. Soc ., 104, p. 6891. This work demonstrates that bright orange chemiluminescence can be based on the aqueous reaction of chemically generated or electrogenerated Ru(bpy) 3 3+ (where "bpy" represents a bipyridyl ligand) with strong reductants produced as intermediates in the oxidation of oxalate ions or other organic acids. Luminescence also can be achieved in organic solvent-H 2 O solutions by the reaction of electrogenerated, or chemically generated, Ru(bpy) 3 1+ with Strong oxidants generated during reduction of peroxydisulfate. A third mechanism for production of electrochemiluminescence from Ru(bpy) 3 2+ involves the oscillation of an electrode potential between a potential sufficiently negative to produce Ru(bpy) 3 1+ and sufficiently positive to produce Ru(bpy) 3 3+ . These three methods are called, respectively, "oxidative-reduction," "reductive-oxidation," and "the Ru(bpy) 3 3+/+ regenerative system". The oxidative-reduction method can be performed in water, and produces an intense, efficient, stable luminescence, which is relatively insensitive to the presence of oxygen or impurities. This luminescence from Ru(bpy) 3 2+ depends upon the presence of oxalate or other organic acids such as pyruvate, lactate, malonate, tartrate and citrate, and means of oxidatively producing Ru(bpy) 3 3+ species. This oxidation can be performed chemically by such strong oxidants as PbO 2 or a Ce(IV) salt. It can be performed electrochemically by a sufficiently positive potential applied either continuously or intermittently. Suitable electrodes for the electrochemical oxidation of Ru(bpy) 3 2+ are, for example, Pt, pyrolytic graphite, and glassy carbon. Although the oxalate or other organic acid is consumed during chemiluminescence, a strong, constant chemiluminescence for many hours can be achieved by the presence of an excess of the consumed material, or by a continuous supply of the consumed material to the reaction chamber. The reductive-oxidation method can be performed in partially aqueous solutions containing an organic cosolvent such as, for example, acetonitrile. This luminescence depends upon the presence of peroxydisulfate and a means of reductively producing Ru(bpy) 3 1+ species. The reduction can be performed chemically by strong reductants such as, for example, magnesium or other metals. It can be performed electrochemically by a sufficiently negative potential applied either continuously or intermittently. A suitable electrode for the electrochemical reduction of Ru(bpy) 3 2+ is, for example, a polished glassy-carbon electrode. As with the oxidative-reduction method, continuous, intense luminescence can be achieved for many hours by inclusion of excess reagents, or by continuous addition of the consumed reagents to the reaction mixture. The Ru(bpy) 3 3+/+ regenerative system can be performed in organic solvents such as acetonitrile or in partially aqueous systems, by pulsing an electrode potential between a potential sufficiently negative to reduce Ru(bpy) 3 2+ and a potential sufficiently positive to oxidize Ru(bpy) 3 2+ . A suitable electrode for such a regenerative system is, for example, a Pt electrode. This system does not consume chemical reagents and can proceed, in principle, for an unlimited duration. These three methods of producing luminescent Ru-containing compounds have in common the repetitive oxidation-reduction or reduction-oxidation of the Ru-containing compound. The luminescence of solutions containing these compounds is therefore highly dependent on the electric potential of the applied energy source, and is therefore highly diagnostic of the presence of a Ru-containing compound. Mandle cites Curtis et al. (1977), "Chemiluminescence; A New Method for Detecting Fluorescent Compounds Separated By Thin Layer Chromatography", J. Chromatography 134, pp. 343-350, as identifying Ru-tris(bipyridyl)(ll) as a possible label in chemlluminescent applications. Curtis et al. reports only unpublished observations that Ru complexes can be induced to emit light when chemically excited by an oxalate/H 2 O 2 system (Curtis et al. p. 350). Neither Mandle nor Curtis recognized the exceptional utility of ruthenium and osmium complexes in chemiluminescent applications or the utility of electrochemilumiscent systems. Sprintschnik, G. et al. (1977), "Preparation and Photochemical Reactivity of Surfactant Ruthenium (II) Complexes in Monolayer Assemblies and at Water-Solid Interfaces", J. Am. Chem. Soc. 99, pp. 4947-4954, have described complexes of tris(2,2'-bipyridine)ruthenium(II) esterified with octadecanol or dehydrocholesterol, and have created monolayer films of these surfactant complexes. The complexes were photoluminescent. But when the films were exposed to water, and then to light, the Ru-complexes failed to photoluminesce. This was attributed to photohydrolysis of ester groups in the presence of light. It has been discovered and is disclosed herein, that a wide variety of analytes of interest and chemical moieties that bind to analytes of interest may be conveniently attached to Ru-containing or Os-containing labels through amide or amine linkages. The labelled materials may then be determined by any of a wide variety of means, but by far the most efficient, reliable, and sensitive means are photoluminescent, chemiluminescent, and electrochemiluminescent means. It is also disclosed herein that electrochemilumiscent labels, including Ru-containing and Os-containing labels and organic molecules such as rubrene and 9,10-diphenyl anthracene, are particularly versatile and advantageous. The great advantages of the use of these novel labelled materials, and of the methods of detecting them, are further discussed hereinbelow. According to the present invention, there is provided a method of determining the presence of a chemical moiety having the formula (A) k (B) u wherein A is a compound which can be induced to emit electrochemiluminescence by direct exposure to an electrochemical energy source; B is a substance which is attached to A; k is an integer equal to or greater than 1; and u is an integer equal to or greater than 1, comprising: a) forming a reagent mixture under suitable conditions containing the chemical moiety; b) inducing the chemical moiety to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy and c) detecting the emitted electrochemiluminescence and thereby determining the presence of the chemical moiety. The present invention also provides for use of electrochemiluminescent labels in binding methods for determining the presence of substances of interest. These methods can be used to determine labelled moieties of interest, to employ labelled moieties to determine analytes of interest, or to use labelled analogues of analytes of interest to determine analytes of interest in competitive binding assays. These binding methods can be homogeneous or heterogeneous binding methods. Detailed Description of the Invention The luminescent species is detected by measuring the emitted electrochemiluminescence. All of these measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time. An example of rate-based measurements Is the use of photomultiplier tubes, photodiodes or phototransistors to produce electric currents proportional in magnitude to the incident light intensity. Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly. The analyte of interest and the chemical moiety can be any pair of substances which are capable of binding together in a specific manner. Such substances include for example, whole cells, subcellular particles, nucleic acids, polysaccharides, proteins, glycoproteins, lipoproteins, lipopolysaccharides, polypeptides, cellular metabolites, hormones, pharmacological agents, tranquilizers, barbituates, alkaloids, steroids, vitamins, amino acids, sugars, and non-biological polymers. Of particular interest are antibody-antigen pairs. For example, this method encompasses the use of labelled antibodies to determine the presence of cell surface antigens, or to label particular cells for detection by cell sorting methods. Antigens immobilized by, for example, attachment to immobilized, unlabelled antibodies can be detected by labelled antibodies in a method commonly known as a "sandwich" method. In competitive binding assays, the analyte of interest and the labelled analogue of the analyte can be any substances capable of participating in formation of a specific complex with a complementary material, such as for example, whole cells, subcellular particles, nucleic acids, polysaccharides, proteins, glycoproteins, lipoproteins, lipopolysaccharides, polypeptides, cellular metabolites, hormones, pharmacological agents, tranquilizers, barbituates, alkaloids, steroids, vitamins, amino acids, sugars and non-biological polymers. Of particular interest are antibody-antigen-based methods. These methods are analogous to the well known radioimmunoassay, wherein an analyte of interest is detected when it displaces a radioactive analogue of the analyte from an antibody. The many variations on radioimmunoassay known to the art can, in principle, be used to advantage by employing moieties labelled according to the present invention in place of radioactively labelled compounds. A particularly unique and useful class of homogeneous binding assays is provided by the present invention. As described hereinbefore, these labels can be measured electrochemically by means of exposing a solution of the labelled substance of interest to an electrode. Any labelled substance which is present in the solution but cannot gain access to the surface of the electrode will not be detected. This can occur. for example, if the labelled substance is bound directly or indirectly to the surface of the reaction vessel into which the electrode is placed, or if the label is imbedded deep into the interior of the specific complex, such as within an antigen-antibody complex, or if the electrode itself were coated with a layer through which labelled material could pass but complexed labelled material could not pass. In addition, it should be possible to coat the surface of an electrode with antibodies, so that only labelled antigen bound to the immobilized antibodies can obtain access to the electrode and thereby be determined. This particular homogenous method may be most effective if the required electrode potential is applied in short pulses. It is within the scope of the present invention to use a combination of means for determining the presence of labelled compounds. For example, it may be desirable to measure the total amount of labelled substance by a means which does not distinguish between bound and unbound labelled substance such as photoluminescence or chemiluminescence, and to determine the mount of bound labelled substance by a means which does distinguish between bound and unbound labelled substance, such as electrochemiluminescence, for example. Such a combination of methods could be performed on the same sample, and thus provide a richer source of information about the sample than could any method when used individually. The systems of the present invention are envisioned to be useful in the rapid, efficient, and versatile performance of the diverse methods disclosed and suggested by the instant invention disclosure. This invention also provides a method of determining the presence of a chemical moiety haying the formula: (A) k (B) u . A is a compound which can be induced to emit electrochemiluminescence by direct exposure to an electrochemical energy source. These compounds can be organometallic or organic compounds, e.g. rubrene, or 9,10-diphenyl anthracene, or ruthenium-containing or osmium-containing labels. B is a substance which is attached to A, k is an integer equal to or greater than one and u is an integer equal to or greater than 1. The method comprises forming a reagent mixture under suitable conditions containing the chemical moiety and inducing the chemical moiety to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy. The emitted electrochemiluminescence is then detected by suitable methods thereby determining the presence of the chemical moiety. Biological and nonbiological substances (B) may be incorporated into the moieties by any form of attachment to A. The attachment may be by coordination to a metal atom present in A or to a ligand of A. The attachment can be through covalent, electrostatic, or hydrogen bonding. The type of linkage will be determined by the suitable chemical groups available for binding on both A and B. Suitable substances (B) include, for example, whole cells, subcellular particles, nucleic acids, polysaccharides, proteins, glycoproteins, lipoproteins, lipopolysaccharides, polypeptides, cellular metabolites, hormones, pharmacological agents, tranquilizers, barbituates, alkaloids, steroids, vitamins, amino acids and sugars. The substances are not limited to biological substances and may be any suitable non-biological substance such as a polymer, organic or inorganic compound. The chemical moiety is induced to emit electrochemiluminescence by creating an excited state of the moiety which luminesces at wavelengths from about 200 nanometers to about 900 nanometers at ambient temperatures. In this embodiment of the invention the chemical moiety is excited by exposing the reagent mixture to electrochemical energy. The potential at which the reduction or oxidation of the inventive chemical moiety will occur depends upon its exact chemical structure as well as factors such as the pH of the solution and the nature of the electrode used. It is well known to those of ordinary skill in the art how to determine the optimal potential and emission wavelength of an electrochemiluminescent system. The electrochemiluminescent species may be measured by any suitable measurement such as the measurement of electric current or emitted electrochemiluminescence. The method of determining the presence of the moiety may also be performed when the moiety is capable of binding to another chemical agent. The chemical agent may be any substance capable of binding to the moiety in a specific manner. Examples of such methods are nucleic acid hyridization techniques, antibody-antigen based techniques and enzyme-ligand techniques. In another embodiment of the invention the electrochemiluminescent moiety, (A) k (B) u may be used in methods to determine the presence of an analyte of interest which binds to the moiety. The analyte of interest can be any substance which is capable of binding to the electrochemiluminescent moiety, such as the binding of an antigen to a antibody labelled with an electrochemiluminescent moiety. The method involves contacting the analyte with the chemical moiety under suitable conditions so as to form a reagent mixture. The chemical moiety is then induced to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy. The presence of the analyte is determined by detecting the electrochemiluminescence emitted by the chemical moiety bound to the analyte. Competitive binding methods may also be used to determine the presence of an analyte of interest. The analyte and the chemical moiety, (A) k (B) u , bind competitively to a chemical material. The material is contacted with the chemical moiety and analyte under suitable conditions so as to form a reagent mixture. The chemical moiety is induced to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy. The presence of the analyte of interest is determined by detecting the amount of emitted electrochemiluminescence. Another embodiment of the invention involves methods and systems of determining one or more different electrochemiluminescent moieties of the formula (A) k (B) u present in the same sample. These chemical moieties contain different compounds which emit electrochemiluminescence of different wavelengths when exposed to an electrochemical energy source or can each be induced to emit electrochemiluminescence by exposure to distinct electrochemical energy sources. These different electrochemiluminescent moieties may be specifically attached to different substances or analytes of interest. Determination of the different moieties involves the same procedures as discussed previously. This invention is illustrated in the examples which follow. EXAMPLE I Preparation of Ruthenium bis (2,2-bipyridine) (2,2'-bipyridine-4,4'-dicarboxylic acid) bis(hexatluorophosphate). Sodium bicarbonate (0.40 g), ruthenium dichlorobis(2,2'-bipyridine)(0.40 g), and 2,2-bipyridine-4,4'-dicarboxylic acid (0.30 g) were stirred in refluxing methanol (20 ml)-water (5 ml) for 9 hours. The resulting solution was cooled in an ice bath, treated with 5 drops concentrated H 2 SO 4 , and allowed to stand at ice temperature for 1.5 hours. A precipitate formed, which was separated by filtration and washed with MeOH (8 ml). The combined filtrate and wash solution were treated with a solution of sodium hexafluorophosphate (5.0 g) in water (25 ml). The resulting solution was cooled in an ice bath for 3 hours, and the resulting precipitate of red-purple crystals was collected by filtration (0.40 g). EXAMPLE II Preparation of Active Ester of Ruthenium bis (2,2'-bipyridine )(2,2'-bipyridine-4,4'-dicarboxylic acid). Dicyclohexylcarbodiimide (DCC, 0.046 g) and N-hydroxysuccinimide (0.034 g) were dissolved in DMF (2 ml) with stirring, and cooled in an ice bath. A solution of ruthenium bis (2,2'-bipyridine) (2,2'-bipyridine-4,4'-dicarboxylic acid) (0.101 g, prepared as in Example I) dissolved in DMF (1 ml) was added, and the mixture was stirred 5 hours at ice bath temperature. A precipitate formed and was separated by centrifugation. The supernatant containing the activated ruthenium complex was retained for labelling of substrates. EXAMPLE III Labelling of Bovine Serum Albumin (BSA) with Activated Ruthenium Complex. The DMF solution of activated ruthenium complex prepared in Example II (1 ml) was added to a stirred solution of BSA in aqueous Physiologic Buffered Saline (PBS, 5 ml; 25 mg/ml BSA). The mixture was stirred overnight, and precipitate was removed by centrifugation. The supernatant containing ruthenium-labelled BSA was analyzed by two methods. METHOD 1: Dialysis Ruthenium-labelled BSA solution was dialyzed with PBS solution. As a control, the unbound, activated ruthenium complex prepared in Example II was also dialyzed with PBS solution. After 8 hours, the control showed no fluorescent species within the dialysis tube. The ruthenium labelled BSA solution, however, showed strong fluorescence, indicating that the ruthenium complex was bound to the high molecular weight BSA. METHOD 2: Microfiltration Ruthenium-labelled BSA solution was placed in an Amicon microconcentrator and centrifuged at 8000 rpm. A small fraction of red-orange solution remained above the filter, and this colored fraction was diluted with wash PBS solution and centrifuged. This procedure was repeated several times. After the fourth wash, colorless solution passed through the filter, while highly red-orange colored material remained above the filter. This result Indicates that the ruthenium complex was bound to the high molecular weight BSA. EXAMPLE IV Labelling of Human Immunoglobulin G (IgG) with Activated Ruthenium Complex. The DMF solution of activated ruthenium complex prepared in Example II was added to a stirred solution of affinity purified human IgG in aqueous buffer. The ruthenium labelled IgG solution fluoresced brightly after extensive dialysis, indicating that the ruthenium complex was bound to the high molecular weight affinity purified human IgG. EXAMPLE V Labelling of Rabbit Anti-salmonella Antibody The DMF solution of activated ruthenium complex prepared In Example II (0.1 ml) was stirred with rabbit serum containing anti- Salmonella antibody (1 ml) at room temperature for 1 hour, and then quenched by addition of diethanolamine (0.1 ml). Salmonella cells were treated with the resultant solution containing ruthenium labelled anti- Salmonella antibody. The cells were separated by centrifugation and resuspended in fresh buffer five times, in order to separate the cells from any unbound antibody (including ruthenium labelled unbound antibody) and from any free ruthenium complex. The Salmonella cells, treated with ruthenium labelled anti- Salmonella antibody, emitted bright red-orange light when viewed on a fluorescence optical microscope, indicating that the anti- Salmonella antibody was labelled with ruthenium complex, and that the ruthenium labelled antibody retained its ability to bind to Salmonella cells under conditions where the ruthenium complex fluoresced. EXAMPLE VI The procedure of Example V was repeated using normal mouse serum (i.e., lacking anti- Salmonella antibody) in place of rabbit serum containing anti- Salmonella antibody. The Salmonella cells, after treatment, did not emit red-orange light when viewed on a fluorescence optical microscope, indicating that non-specific binding of ruthenium labelled normal mouse serum components to Salmonella cells did not occur. Comp. EXAMPLE VII Labelling of Goat Anti-Rabbit Immunoglobulin (IgG) and Comparison with Rhodamine The DMF solution of activated ruthenium complex prepared in Example II was added to a stirred solution of affinity purified goat anti-rabbit IgG. After reaction, the mixture was dialyzed against buffer. Material remaining in the dialysis tube fluoresced under UV light. The ruthenium labelled IgG was tested for reactivity toward Salmonella coated with rabbit anti- Salmonella antibodies. Rabbit anti- Salmonella antibodies were reacted Salmonella worthington that had been fixed to a glass microscope slide, and unreacted antibody was washed away with buffer. The ruthenium label led goat anti-rabbit IgG was then reacted with the antibody treated S. worthington, and unreacted material was washed away with buffer. The slide was examined under an optical microscope equipped with a 50 W mercury lamp, and very bright orange-red fluorescence was observed on and around the bacterium. A control experiment tested for non-specific binding of ruthenium-labelled antibody. S. worthington, fixed to a glass microscope slide, was reacted with normal mouse serum, and then with ruthenium labelled goat anti-rabbit IgG antiserum. The same washing procedures were followed. No orange-red fluorescence was observed. For comparison purposes, a rhodamine isothiocyanate conjugated goat anti-rabbit IgG antiserum (at a protein concentration equivalent to the ruthenium-conjugated antibody) was reacted with S. worthington coated with rabbit anti- Salmonella antibodies. Red fluorescence was barely detectable and the intensity of fluorescence was significantly less than the ruthenium conjugate. EXAMPLE VIII Electrochemiluminescent (ECL) Detection of Ruthenium Labelled Bovine Serum Albumin (BSA). ECL measurements were carried out in a one compartment cell (30 ml) with an optically flat bottom. The working electrode was glassy carbon, the counter electrode was platinum gauze, and the pseudoreference electrode was a silver wire. Light intensity measurements were made by applying a potential of -2.0v (versus the Ag wire), detecting the emitted light with a photomultiplier tube (Hamamatsu 928), and integrating the resulting signal for 2 s with a Bascom-Turner Recorder. Acetonitrile-water (9 ml, 50:50 v/v), tetrabutylammonium tetrafluoroborate (329 mg), and diammonium peroxydisulfate (42 mg) were mixed in the ECL cell, and background light intensity was recorded. Ruthenium labelled BSA solution (prepared in Example III) was diluted in acetonitrile-water (50:50 v/v) and the diluted BSA solution (1 ml) was added to the ECL cell. The resulting solution was deaerated by bubbling solent-saturated nitrogen. Table I summarizes results for different concentrations of ruthenium labelled BSA. Light Intensity (Arbitrary Units) (Ruthenium) M 5.2 blank 20.63 1 x 10 -11 33.25 1 x 10 -10 54.42 9 x 10 -10 150.2 8 x 10 -9 EXAMPLE IX Preparation of 4,4'-Di(chloromethyl)-2,2'-bipyridine-bis (2,2'-bipyridine) ruthenium (II) 2+ 4,4'-Diethoxycarbonyl-2,2'-bipyridine was prepared from 2,2-bipyridine-4,'dicarboxylic acid by the method of Sprintschink et al. (J. Amer. Chem. Soc. 99 , 4947 (1977)). The diethyl ester (100 mg) was dissolved in anhydrous diethyl ether (35 ml). Lithium aluminum hydride (100 mg) was added, and following a 30 minute incubation diethyl ether (35 ml) and ice cold deionized water (100 ml) were added. The solution was mixed throughly and the ether layer collected. The aqueous phase was extracted twice more with ether (70 ml). The combined ether extracts were dried over anhydrous sodium sulfate and filtered. The solvent was removed on a rotary evaporator to give the desired product (43 mg). This 43 mg of 4,4-Di(hydroxymethyl)-2,2'-bipyridine and 120 mg of cisdichloro bis (2,2'-bipyridine) ruthenium (II) dihydrate were added to ethanol (25 ml), and the solution was refluxed for 14 hours. After the solution had cooled, 50 ul of solution of ammonium hexafluorophosphate (1 gm in 1 ml of water) was added, the resultant crystalline solid was collected, washed with a small volume of ethanol and dried to give 138 mg of the hexafluorophosphate salt of the 4,4-dihydroxymethyl complex. This complex (6 mg) was added to thionyl chloride (5 ml), and the solution was refluxed for 6 hours. The thionyl chloride was removed by distillation, and the solid residue was dissolved in a dioxane-water (1:1) mixture (500 ul). This solution containing 4,4'Di(chloromethyl)-2,2'-bipyridine-bis-(2,2'-bipyridine) ruthenium (II) 2+ was used for labeling of antibody. EXAMPLE X Labeling of Rabbit and Sheep Anti-Mouse IgG with 4, 4'-Di(chloromethyl)-2,2'-bipyridine-bis- (2,2'-bipyridine) ruthenium (II) 2+ The rabbit and sheep antibodies were received as 2 mg/ml solutions in PBS. These soiutions were dialyzed overnight against sodium bicarbonate (500 ml, 50 mM, pH9). The antibody (2 mg) was then diluted with sodium bicarbonate solution to give a final volume of 2 ml. This solution (1 ml) was added to sodium carbonate solution (1 ml, 50 mM) to adjust the pH to 10. The solution of activated complex in dioxane-water (100 ul) was added to the solution of antibody and allowed to react at 4°C for 16 hours. After this, BSA (5 mg) was added to the reaction, and the solution was immediately dialyzed against carbonate buffer (500 ml, 25 mM, pH9). The dialysis buffer was changed three times at 24 hour intervals. Comp. EXAMPLE IX Demonstration of immunological Reactivity of Labeled Rabbit and Sheep Anti-Mouse Immunoglobulin by Fluorometric Analysis A formalinized suspension of Legionella pneumophila I (Philadelphia I isolate) was adjusted to an optical density (at 425 nm) of 1.00 by dilution with PBS buffer. A 1.3 dilution (1 ml) of this suspension was added to a series of conical microcentrifuge tubes. The cells were centrifuged (10 minutes, 10,000 RPM), the supematant was decanted, and the cells were resuspended in a 1:100 dilution in PBS (1 ml) of a mouse monoclonal IgG antibody ("10C8", 0.85 mg/ml) or in PBS as a negative control. After incubation at room temperature for 1 hour, the cells were centrifuged as before, the supematant was decanted, the cells were resuspended in PBS buffer and centrifuged again. Following decantation of the supematant, the cells were resuspended in a 1:5 dilution (in PBS) of the pooled ruthenium labeled rabbit and sheep anti-mouse IgG Antibody (1 ml. 10 mg ruthenium complex/ml), or In a 1:50 dilution (in PBS) of fluorescein labeled goat anti-mouse IgG antibody (1 ml, 0.5 mg IgG/ml) as a positive control, or in PBS as a negative control. After incubation at room temperature for 1 hour, the cells were centrifuged as before, the supernatant was decanted, and the cells resuspended in PBS and washed twice, with centrifugation, as before. Following the last wash the cells were resuspended in PBS (1 ml) and transferred to a polystyrene cuvette for fluorometric analysis. Excitation and emission scans of the fluorescein labeled goat anti-mouse IgG antibody solution showed an excitation peak at 491 nm and an emission peak at 519 nm. These wavelengths were used for the fluorescence measurements of the fluorescein labeled cells. Excitation and emission scans of the ruthenium labeled rabbit/sheep anti-mouse IgG antibody solution showed an excitation peak at 455 nm and an emission peak at 623 nm. These wavelengths were used for the fluorescence measurements of the ruthenium labeled cells. Cell suspensions which had been incubated with PBS instead of primary "10C8" antibody and fluorescent conjugate served as negative controls and were used to blank the fluorometer. The fluorescence of cell suspensions which had been incubated with both primary "10C8" antibody and fluorescent conjugate was defined as 100, and all other fluorescence measurements were made in fluorescence units relative to these internal standards. Table I summarizes the results, which demonstrate that the ruthenium labeled anti-mouse IgG conjugate fluoresces and exhibits specific immunological reactivity in the presence of primary "10C8" antibody. RELATIVE FLUORESCENCE UNITS Fluorescein (at 519 nm) Ruthenium (at 623 nm) 1:3 cell Dilution 1:3 cell Dilution Fluorescence of conjugate with primary antibody ≡100 ≡100 Fluorescence of conjugate without primary antibody 37 64 Background fluorescence (with primary antibody, without conjugate) 6 48

Claims: A method of determining the presence of a chemical moiety having the formula (A) k (B) u wherein: A is a compound which can be induced to emit electrochemiluminescence by direct exposure to an electrochemical energy source; B is a substance which is attached to A; k is an integer equal to or greater than 1; and u is an integer equal to or greater than 1, comprising: a) forming a reagent mixture under suitable conditions containing the chemical moiety; b) inducing the chemical moiety to emit electrochemiluminescence by directly exposing the molety to electrochemical energy; and c) detecting the emitted electrochemiluminescence and thereby determining the presence of the chemical moiety. A method according to claim 1, wherein the moiety is capable of binding to a chemical agent. A method of determining the presence of an analyte of interest which binds to a chemical moiety having the formula: (A) k (B) u wherein: A is a compound which can be induced to emit electrochemiluminescence by direct exposure to an electrochemical energy source; B is a substance which is attached to A; k is an integer equal to or greater than 1; and u is an integer equal to or greater than 1, comprising: a) contacting the analyte with the chemical moiety under suitable conditions so as to form a reagent mixture; b) inducing the chemical moiety to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy; and c) detecting the emitted electrochemiluminescence and thereby determining the presence of the analyte of interest. A competitive binding method of determining the presence of an analyte of interest wherein the analyte and a chemical moiety bind competitively to a chemical material, the chemical moiety having the formula: (A) k (B) u wherein: A is a compound which can be induced to emit electrochemiluminescence by direct exposure to an electrochemical energy source; B is a substance which is attached to A; k is an integer equal to or greater than 1; and u is an integer equal to or greater than 1, comprising: a) contacting the material, the chemical moiety and the analyte under suitable conditions so as to form a reagent mixture; b) inducing the chemical moiety to emit electrochemiluminescence by directly exposing the moiety to electrochemical energy; and c) detecting the emitted electromagnetic radiation and thereby determining the presence of the analyte of interest. A method according to claim 1, 2, 3, or 4 wherein A comprises rubrene or 9,10-diphenyl anthracene. A method according to claims 1, 2, 3, 4, or 5, wherein A is ruthenium. A method according to claim 1, 2, 3, 4, 5 or 6, wherein B is an antibody. A method according to claim 1, 2, 3, 4, 5, 6 or 7, wherein A is attached to B via an amide bond. A method according to claim 1, 2, 3, 4, 5, 6, 7, or 8, wherein said chemical moiety comprises tris (2, 2-bipyridyl) ruthenium (II). A method according to claim 1, 2, 3, 4, 5 or 6, wherein B is nucleic acid.

Inventors: BARD ALLEN J, WHITESIDES GEORGE M, BARD, ALLEN J., WHITESIDES, GEORGE M.
Applicants: IGEN INT INC, IGEN INTERNATIONAL, INC.
Application year: 1993
Main classification: G01N33
IPC codes: C07F15, G01N33